Strs Ohio Sells 58,434 Shares of Ralliant Corporation $RAL

Strs Ohio cut its position in Ralliant Corporation (NYSE:RAL) by 95.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,706 shares of the company’s stock after selling 58,434 shares during the quarter. Strs Ohio’s holdings in Ralliant were worth $118,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Dodge & Cox bought a new position in Ralliant during the second quarter worth about $523,571,000. Viking Global Investors LP bought a new stake in shares of Ralliant during the 2nd quarter valued at $257,200,000. State Street Corp bought a new position in Ralliant in the 2nd quarter worth about $213,096,000. Flossbach Von Storch SE purchased a new position in Ralliant during the 2nd quarter valued at about $198,077,000. Finally, Norges Bank purchased a new stake in shares of Ralliant in the second quarter worth about $108,453,000.

Analyst Upgrades and Downgrades

Several brokerages recently commented on RAL. Oppenheimer boosted their price objective on shares of Ralliant from $55.00 to $60.00 and gave the company an “outperform” rating in a research note on Monday, December 15th. Citigroup raised shares of Ralliant from a “neutral” rating to a “buy” rating and raised their price target for the company from $53.00 to $61.00 in a report on Monday, December 8th. Royal Bank Of Canada upped their price target on shares of Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a report on Friday, November 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a research note on Monday, December 29th. Finally, Truist Financial began coverage on Ralliant in a research report on Friday, December 12th. They set a “buy” rating and a $62.00 target price for the company. Six investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $58.00.

More Ralliant News

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Q4 operating beat — Ralliant reported $0.69 EPS (vs. $0.67 consensus) and revenue was up ~1% year/year, showing continued operational resilience. Ralliant (RAL) Reports Q4 Earnings
• Positive Sentiment: End-market tailwind — coverage highlighted a surge in test & measurement equipment demand, which supports revenue prospects for the Test & Measurement segment if orders convert to bookings. All eyes on Ralliant earnings as test equipment demand surges
• Neutral Sentiment: Analytical context — commentators are dissecting Ralliant’s return-on-equity and other metrics to separate one-time accounting impacts from ongoing fundamentals. Useful for longer‑term valuation work but unlikely to move price sharply by itself. Read This Before Judging Ralliant Corporation’s (NYSE:RAL) ROE
• Negative Sentiment: EPS guidance miss — Ralliant set FY2026 EPS guidance of $2.220–2.420 vs. consensus ~2.71, and Q1 guidance of $0.460–0.520 vs. consensus ~$0.53. Lowered EPS outlook is a clear near‑term negative for valuation and analyst estimates. Ralliant Corporation Posts Q4 Results and Issues 2026 Outlook
• Negative Sentiment: Large non-cash goodwill impairment — the company recorded a $1.4B impairment in the Test & Measurement segment, producing a GAAP net loss of about $1.4B (≈$12.10/share). This is an accounting‑level charge but it raises questions about asset values and segment outlook. Ralliant Reports Fourth Quarter and Full Year 2025 Results

Ralliant Trading Up 2.5%

Shares of RAL stock opened at $56.11 on Thursday. The business has a 50-day moving average price of $51.92 and a two-hundred day moving average price of $46.83. Ralliant Corporation has a 12-month low of $40.70 and a 12-month high of $57.02. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. The firm has a market cap of $6.33 billion and a P/E ratio of 44.18.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s payout ratio is presently 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.